Lucid Diagnostics Inc. (LUCD) vs Tenaya Therapeutics, Inc. (TNYA)
A side-by-side comparison of Lucid Diagnostics Inc. and Tenaya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNYA
Tenaya Therapeutics, Inc.
$0.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LUCD vs TNYA
growth of $100 · dividends reinvested · last 5yLUCD -95.0% (-45.0%/yr)TNYA -96.9% (-50.2%/yr)LUCD compounded faster over this window
LUCD TNYA
LUCD vs TNYA: by the numbers
- •TNYA is the larger company ($119M vs $114M market cap).
- •Both run net losses; LUCD's is the smaller (-959.76% vs -7723.97% net margin).
Metrics side by side
Valuation
| Metric | LUCD | TNYA |
|---|---|---|
| P/S ratio | 21.02 | 88.83 |
| P/B ratio | 10.48 | 1.71 |
Profitability
| Metric | LUCD | TNYA |
|---|---|---|
| Gross margin | -60.26% | 0.00% |
| Operating margin | -1054.82% | 0.00% |
| Net margin | -959.76% | -7723.97% |
| ROE | -478.26% | -148.56% |
| ROIC | -145.10% | -142.06% |
Growth (annualized)
| Metric | LUCD | TNYA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -52.81% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.